To further explore the effects of G9a inhibitors on tumor immunity, we used flow cytometric analysis found that MDSCs decreased but CD8+ T cells increased in BALB/C mice treated with G9a inhibitor (Fig. 7M). The gene discussed is CD8A; the disease is neoplasm.